Active Ingredient History
Ketoprofen is a drug belonging to the family of non-steroidal anti-inflammatory drugs. Ketoprofen, was synthesized in France by Rhône-Poulenc chemists in 1967, and introduced in 1973 in France and the United Kingdom for antiinflammatory use. Ketoprofen selectively inhibits isoform-I of cyclo-oxygenase, COX-1. Ketoprofen has shown to be an excellent choice of drug for the treatment of chronic pain in patients with osteoarthritis, rheumatoid arthritis. In addition Ketoprofen is prescribed for management of pain (acute forms of pain, traumatic and post-surgical pain) and also indicated for treatment of primary dysmenorrhea NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arthritis, Rheumatoid (approved 1992)
Dysmenorrhea (approved 1992)
Osteoarthritis (approved 1992)
Pain (approved 1992)
Acute Pain (Phase 3)
Analgesics, Opioid (Phase 3)
Ankle Injuries (Phase 4)
Arthralgia (Phase 3)
Bursitis (Phase 3)
Cesarean Section (Phase 4)
Child (Phase 4)
Cholecystectomy (Phase 3)
Chronic Periodontitis (Phase 2/Phase 3)
Depressive Disorder, Major (Phase 1)
General Surgery (Phase 4)
Genital Diseases, Female (Phase 2/Phase 3)
Headache (Phase 3)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Inflammation (Phase 3)
Knee Injuries (Phase 4)
Low Back Pain (Phase 4)
Lymphedema (Phase 4)
Migraine Disorders (Phase 3)
Migraine with Aura (Phase 3)
Migraine without Aura (Phase 3)
Musculoskeletal Pain (Phase 3)
Myalgia (Phase 2)
Neuralgia (Phase 4)
Osteoarthritis (Phase 3)
Osteoarthritis, Knee (Phase 3)
Pain (Phase 4)
Pain Management (Phase 4)
Pain, Postoperative (Phase 4)
Pharmacokinetics (Phase 1)
Pharyngitis (Phase 4)
Postoperative Nausea and Vomiting (Phase 3)
Recovery of Function (Phase 4)
Renal Colic (Phase 4)
Sciatica (Phase 4)
Shoulder Injuries (Phase 2)
Soft Tissue Injuries (Phase 3)
Sprains and Strains (Phase 3)
Tendinopathy (Phase 3)
Thoracic Surgery (Phase 2)
Tonsillitis (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
